TickerFacts.

Bioventus Inc. (BVS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$100.99M
Year ended 2025-12-31
$103.53M
Trailing 12 months to 2026-06-27
+15.2%
5-year compound annual growth
2019-12-31: $61.51M2020-12-31: $49.88M2021-12-31: $46.94M2022-12-31: -$111.84M2023-12-31: -$24.36M2024-12-31: $34.36M2025-12-31: $100.99M$100.99M
2019-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$100.99M+193.9%2026-03-05, From 2025-01-01
2024-12-31$34.36Mn/m2026-03-05, From 2024-01-01
2023-12-31-$24.36Mn/m2026-03-05, From 2023-01-01
2022-12-31-$111.84Mn/m2025-03-11, From 2022-01-01
2021-12-31$46.94M-5.9%2024-03-12, From 2021-01-01
2020-12-31$49.88M-18.9%2023-03-31, From 2020-01-01
2019-12-31$61.51Mn/a2022-03-11, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Bioventus Inc. (BVS)2025-12-31$100.99M+193.9%
UFP Technologies Inc (UFPT)2025-12-31$111.49M+16.6%
Glaukos Corp (GKOS)2025-12-31-$161.51Mn/m
NovoCure Ltd (NVCR)2025-12-31-$139.15Mn/m
Artivion, Inc. (AORT)2025-12-31$56.20M-10.9%
iRhythm Holdings, Inc. (IRTC)2025-12-31-$36.66Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31-$4.64Mn/m
Mimedx Group, Inc. (MDXG)2025-12-31$78.77M+21.4%
Accuray Inc (ARAY)2026-06-30-$18.50Mn/m

Compare BVS, UFPT, GKOS, NVCR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗